Full Text
Reimbursement and Pricing of Innovative Medicines- EU5 Policies and Implications for Market Access

Abstract

Authors

G Nwogu A Brown K Falk G Murray L Pritchett A Wiesinger

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×